CASI Pharmaceuticals Appoints Daniel Lang As CFO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 08 2024
0mins
Source: Business Insider
- Appointment of Daniel Lang: CASI Pharmaceuticals, Inc. appointed Daniel Lang as Chief Financial Officer and Senior Vice President effective July 8, 2024.
- Experience of Daniel Lang: Lang has over 30 years of experience as a physician scientist, investor, and biotech executive, with a background in cardiology and investment management.
- Previous Roles: He served as the President of Athenex cell therapy division and led clinical development of the NKT cell platform.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
